Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Procter & Gamble Health Limited (NSE: PGHL), ISIN INE199A01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PGHL last traded at ₹5672.50 (-0.77%), with a 52-week range of ₹4707.00 to ₹6975.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.82%, FIIs 6.43%, DIIs 12.63%, mutual funds 8.89%.
EquiSense Score (ECS): 70/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.